The Latest Breaking News from Merck

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

Moderna and Merck team up in new study.

Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results sent Moderna shares soaring.

Indonesia will produce drugmaker Merck Co's vaccines for human papillomavirus (HPV), the chief of its state-owned pharmaceutical company Bio Farma said on Tuesday, in a bid to combat HPV-linked cervical cancer in the country.

The Food and Drug Administration approved Mirati's rival to Amgen's lung cancer drug, sending MRTX stock higher on Tuesday.

Wondering how to invest in stocks and mutual funds amid a grim market? Red-hot Invesco Comstock Select Fund is doubling down on its strategy.

After signs of cooling inflation, investors are hopeful that the Fed will slow its rate hikes over the coming months. With surging optimism, fundamentally strong stocks Merck (MRK), Coca-Cola (KO), and Verizon (VZ), which have seen increased insider buying, might be ideal investments now. Continue reading.

Big Pharma suitors could be looking to buy Mirati Therapeutics, according to reports that sent MRTX stock close to a breakout Wednesday.

Gilead Sciences' first-in-class cancer drug and GILD stock are finally hitting their stride. The oncology business is growing bullishly.